Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation® Canada

Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long COVID.

OMF Welcomes Alain Moreau, PhD, to our Scientific Advisory Board

Photo of Alan Moreau

Dr. Alain Moreau joins the OMF Scientific Advisory Board

OMF is honored to welcome Canadian researcher, Dr. Alain Moreau, to our Scientific Advisory Board (SAB,) which is directed by Ronald W. Davis. PhD.

“I initially decided to invite Dr. Moreau to join our ME / CFS Working Group because he demonstrated that he could take multiple novel approaches to understanding the disease. For example, he has conducted an extensive analysis of the microRNAs that can exert major controls over cell function. It is clear that his work will be very complementary to the research of other investigators.  I was pleased to invite him to join the OMF Scientific Advisory Board. It extends our international collaboration for solving Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS).” Ron Davis, PhD

Recently, Dr. Moreau was appointed Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis Research Network, a national research network funded by the Canadian Institute of Health Research.

Additionally, a generous Canadian family made an anonymous, designated gift to OMF Canada of $1.2 million over two years to support ME / CFS research undertaken in Dr. Moreau’s Montreal-based laboratory.

“The support of Open Medicine Foundation Canada arrives at a critical time for my team, and we wish to thank all of you who are contributing to our research efforts to decipher the Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) enigma. I truly believe that we are at the brink of a breakthrough. Still, success will come only by working in a collaborative manner, not in silos, because together we can achieve the excellence necessary to end ME / CFS”. Alain Moreau PhD

Welcome, Dr. Moreau, to OMF’s global collaboration team.

Learn more about Dr. Moreau